14,992 Shares in Maximus, Inc. (NYSE:MMS) Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 14,992 shares of the health services provider's stock, valued at approximately $1,113,000.

A number of other hedge funds have also bought and sold shares of the business. Sanctuary Advisors LLC purchased a new stake in shares of Maximus during the 2nd quarter valued at $216,000. GAMMA Investing LLC grew its position in Maximus by 150.6% during the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider's stock valued at $80,000 after buying an additional 518 shares during the period. Inspire Investing LLC increased its holdings in Maximus by 8.1% during the third quarter. Inspire Investing LLC now owns 4,445 shares of the health services provider's stock worth $414,000 after buying an additional 333 shares during the last quarter. Creative Planning raised its position in Maximus by 7.8% in the third quarter. Creative Planning now owns 16,386 shares of the health services provider's stock worth $1,527,000 after acquiring an additional 1,181 shares during the period. Finally, Washington Capital Management Inc. raised its position in Maximus by 22.2% in the third quarter. Washington Capital Management Inc. now owns 5,500 shares of the health services provider's stock worth $512,000 after acquiring an additional 1,000 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

Maximus stock traded down $0.63 during midday trading on Wednesday, reaching $67.13. The stock had a trading volume of 560,923 shares, compared to its average volume of 723,176. The firm has a market capitalization of $3.83 billion, a PE ratio of 14.44 and a beta of 0.72. Maximus, Inc. has a 12 month low of $66.52 and a 12 month high of $93.97. The company has a quick ratio of 1.49, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm's 50-day moving average price is $74.51 and its 200 day moving average price is $82.95.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts predict that Maximus, Inc. will post 6.05 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. Maximus's dividend payout ratio (DPR) is 25.81%.

Insiders Place Their Bets

In other news, CEO Bruce Caswell purchased 3,500 shares of the firm's stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Raymond B. Ruddy acquired 3,490 shares of the company's stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the purchase, the director now directly owns 112,520 shares of the company's stock, valued at $8,040,679.20. This trade represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 7,063 shares of company stock worth $502,017 in the last quarter. 1.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MMS. StockNews.com upgraded shares of Maximus from a "hold" rating to a "buy" rating in a research note on Thursday, February 6th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.